Literature DB >> 10231644

Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease).

J J Swigris1, J W Olin, N A Mekhail.   

Abstract

Thromboangiitis obliterans (Buerger's disease) is a segmental inflammatory vasculitis that involves the small-sized and medium-sized arteries, veins, and nerves. It is causally related to tobacco use. The diagnosis is usually made on the basis of the presence of distal arterial disease in individuals who smoke and in whom other disease entities have been excluded. The most effective treatment for Buerger's disease is smoking cessation. Without strict adherence to tobacco avoidance, disease progression is likely. Methods to control ischemic pain include medications, sympathectomy, or surgical revascularization. The effect of sympathectomy is unpredictable, and the chances of a successful revascularization procedure are rare because distal target vessels often are extensively diseased. Herein, we describe a patient whose condition did not respond to the usual conservative therapy but did respond dramatically to the implantation of a permanent spinal cord stimulator. Although these devices have been used for more than 20 years in various other peripheral arterial diseases, their use in Buerger's disease has been limited.

Entities:  

Mesh:

Year:  1999        PMID: 10231644     DOI: 10.1016/s0741-5214(99)70221-1

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Thromboangiitis Obliterans (Buerger's Disease).

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

2.  Treatment of digit ulcers in a patient with Buerger's disease by using cervical spinal cord stimulation -a case report-.

Authors:  Sang-Wook Ryu; Hee-Jung Jeon; Sam-Soon Cho; Rak-Min Choi; Jin-Sun Yoon; Hong-Seok Ko; Jae-Do Lee
Journal:  Korean J Anesthesiol       Date:  2013-08-27

3.  Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue.

Authors:  Kosmas I Paraskevas
Journal:  Clin Rheumatol       Date:  2008-02-02       Impact factor: 2.980

4.  Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practices.

Authors:  Edwaldo Edner Joviliano; Renata Dellalibera-Joviliano; Marcelo Dalio; Paulo Rb Evora; Carlos E Piccinato
Journal:  Int J Angiol       Date:  2009

5.  Extreme distal bypass to improve wound healing in Buerger's disease.

Authors:  Giovanni De Caridi; Mafalda Massara; Simona Villari; Eugenio Martelli; Francesco Spinelli; Raffaele Grande; Lucia Butrico; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2014-02-25       Impact factor: 3.315

6.  Thromoboagiitis Obliterans (TAO).

Authors:  Ui-Jun Park; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

Review 7.  Conditions presenting with symptoms of peripheral arterial disease.

Authors:  Aditya M Sharma; Patrick T Norton; Daisy Zhu
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

Review 8.  Thromboangiitis obliterans (Buerger's disease).

Authors:  Perttu E T Arkkila
Journal:  Orphanet J Rare Dis       Date:  2006-04-27       Impact factor: 4.123

9.  The infrapopliteal arterial occlusions similar to buerger disease: report of two cases.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Yoshinori Inoue; Takehisa Iwai
Journal:  Case Rep Vasc Med       Date:  2014-11-06

Review 10.  The Effects of Spinal Cord Stimulators on End Organ Perfusion: A Literature Review.

Authors:  Harneel S Saini; Mina Shnoda; Ishveen Saini; Matthew Sayre; Shahzaib Tariq
Journal:  Cureus       Date:  2020-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.